Skip to content
PubMed This is a summary of 10 peer-reviewed journal articles Updated
Neurology

Recognizing NMOSD Symptoms and Identifying Attacks

At a Glance

NMOSD causes severe attacks on the central nervous system, leading to vision loss, spinal cord inflammation, and uncontrollable hiccups or vomiting. Recognizing these signs quickly is critical, as seeking emergency treatment within 24 hours is the best way to prevent permanent nerve damage.

Because NMOSD is “attack-driven,” recognizing the signs of a new flare-up is one of the most important skills you can develop. In NMOSD, the immune system targets specific areas of the central nervous system, leading to six “core” clinical characteristics [1][2]. Understanding these symptoms can help you and your medical team act quickly to prevent permanent damage.

The Six Core Symptoms of NMOSD

Medical guidelines identify six specific ways NMOSD typically presents [1]:

  1. Optic Neuritis: Inflammation of the optic nerve. This often feels like sudden blurred vision, “blind spots,” or loss of color vision, usually accompanied by pain when moving the eye [3]. While it can affect just one eye, NMOSD frequently affects both eyes simultaneously (unlike MS) [1].
  2. Acute Myelitis: Inflammation of the spinal cord. In NMOSD, this is often “longitudinally extensive” (LETM), meaning the inflammation spans three or more vertebrae in length [4][5]. It can cause sudden weakness or paralysis in the legs or arms, loss of bladder/bowel control, and a “squeezing” sensation around the torso known as an “NMO hug” [6][1].
  3. Area Postrema Syndrome: This is a classic “red flag” for NMOSD [1]. It involves bouts of intractable (uncontrollable) hiccups, nausea, or vomiting that can last for days or weeks [1][7]. Because these symptoms seem like a digestive problem, they are often misdiagnosed as food poisoning or a stomach bug.
  4. Acute Brainstem Syndrome: This occurs when the brainstem is affected, potentially leading to double vision, vertigo (dizziness), or facial numbness [1][7].
  5. Diencephalic Syndrome: Damage to the deeper parts of the brain (the diencephalon) can cause unusual symptoms like extreme, uncontrollable sleepiness (symptomatic narcolepsy), confusion, or changes in appetite and temperature regulation [1][8].
  6. Cerebral Syndrome: This involves inflammation in the large part of the brain (the cerebrum), which can lead to cognitive impairment, behavioral changes, or even psychosis-like symptoms in rare cases [1][9].

What Constitutes a “True Attack”?

Not every new ache or pain is an NMOSD relapse. Doctors distinguish between a “true attack” and a “pseudo-relapse” [1]:

  • A True Attack (Relapse): This is a new or significantly worsening neurological symptom that lasts for at least 24 hours and is not caused by another factor like an infection [1]. These are medical emergencies because each attack can cause permanent damage to the astrocytes [6][10].
  • A Pseudo-Relapse: This is a temporary return of old symptoms. It usually happens when the body is under stress from heat, a fever, an infection (like a UTI), or extreme exhaustion. Once the stressor is gone (e.g., the fever breaks), the symptoms typically fade back to your baseline.

When to Seek Immediate Help

You should contact your neurology team or go to the emergency room immediately if you experience “Red Flag” symptoms, including:

  • Sudden, severe vision loss in one or both eyes [1].
  • New or rapidly worsening weakness in your legs or arms [6].
  • Sudden loss of bladder or bowel control [1].
  • Hiccups, nausea, or vomiting that won’t stop and have no clear cause [1].

Acting within the first 24–48 hours of an attack gives treatments like high-dose steroids or plasma exchange (a process that filters antibodies out of your blood) the best chance of minimizing damage [10].

Common questions in this guide

What are the core symptoms of NMOSD?
NMOSD typically presents with six core symptoms. The most common include optic neuritis (vision loss and eye pain), acute myelitis (spinal cord inflammation causing weakness), and area postrema syndrome (uncontrollable hiccups and vomiting).
What is the difference between an NMOSD attack and a pseudo-relapse?
A true attack is a new or significantly worsening neurological symptom that lasts for at least 24 hours. A pseudo-relapse is a temporary return of old symptoms triggered by a stressor like heat, fever, or an infection, which fades when the stressor resolves.
Why is area postrema syndrome often misdiagnosed?
Area postrema syndrome causes days or weeks of uncontrollable hiccups, nausea, or vomiting. Because these symptoms mimic digestive problems, it is frequently mistaken for a stomach bug or food poisoning rather than a neurological issue.
When should I seek emergency medical help for NMOSD symptoms?
You should seek immediate help if you experience sudden vision loss, new or rapidly worsening weakness in your limbs, loss of bowel or bladder control, or persistent hiccups and vomiting. Early treatment within 24 to 48 hours is critical.
How are acute NMOSD attacks treated?
Severe NMOSD attacks are medical emergencies. Standard acute treatments include high-dose intravenous steroids to reduce inflammation and plasma exchange to filter harmful antibodies out of your blood.

Questions to Ask Your Doctor

Curated prompts to bring to your next appointment.

  1. 1.Do my current symptoms align with any of the six 'core' clinical characteristics of NMOSD?
  2. 2.Is my AQP4-IgG antibody status positive, and how does that change the symptoms we should be watching for?
  3. 3.How can I tell the difference between a minor fluctuation and a 'true attack' that requires emergency care?
  4. 4.Who should I call if I start experiencing 'Area Postrema Syndrome' (hiccups or vomiting) to ensure it isn't misdiagnosed as a stomach issue?
  5. 5.What is the protocol for emergency treatment (like steroids or plasma exchange) if I suspect a new attack?

Questions For You

Tap a prompt to share your answer — we'll use it plus this page's context to start a tailored conversation.

References

References (10)
  1. 1

    International consensus diagnostic criteria for neuromyelitis optica spectrum disorders.

    Wingerchuk DM, Banwell B, Bennett JL, et al.

    Neurology 2015; (85(2)):177-89 doi:10.1212/WNL.0000000000001729.

    PMID: 26092914
  2. 2

    Neuromyelitis optica spectrum disorders.

    Paul S, Mondal GP, Bhattacharyya R, et al.

    Journal of the neurological sciences 2021; (420()):117225 doi:10.1016/j.jns.2020.117225.

    PMID: 33272591
  3. 3

    AQP4-IgG positive paraneoplastic NMOSD: A case report and review.

    Ding M, Lang Y, Cui L

    Brain and behavior 2021; (11(10)):e2282 doi:10.1002/brb3.2282.

    PMID: 34520629
  4. 4

    Spectrum of MRI brain lesion patterns in neuromyelitis optica spectrum disorder: a pictorial review.

    Wang KY, Chetta J, Bains P, et al.

    The British journal of radiology 2018; (91(1086)):20170690 doi:10.1259/bjr.20170690.

    PMID: 29388807
  5. 5

    Atypical Pediatric Demyelinating Diseases of the Central Nervous System.

    Troxell RM, Christy A

    Current neurology and neuroscience reports 2019; (19(12)):95 doi:10.1007/s11910-019-1015-y.

    PMID: 31773416
  6. 6

    Multiple sclerosis and neuromyelitis optica spectrum disorders: some similarities in two distinct diseases.

    Yokote H, Mizusawa H

    Neural regeneration research 2016; (11(3)):410-1 doi:10.4103/1673-5374.179048.

    PMID: 27127473
  7. 7

    Central Sleep Apnea Syndrome Can Complicate Neuromyelitis Optica Spectrum Disorder: A Case Report.

    Morelli C, Aeby A, Scaillet S, et al.

    Frontiers in pediatrics 2020; (8()):547474 doi:10.3389/fped.2020.547474.

    PMID: 33102404
  8. 8

    Associations between neuromyelitis optica spectrum disorder, Sjögren's syndrome, and conditions with electrolyte disturbances.

    Akaishi T, Tarasawa K, Matsumoto Y, et al.

    Journal of the neurological sciences 2023; (452()):120742 doi:10.1016/j.jns.2023.120742.

    PMID: 37515845
  9. 9

    Autonomic Dysregulation, Cognitive Impairment, and Symptoms of Psychosis as an Unusual Presentation in an Anti-Aquaporin 4-Positive Patient.

    Ruiter AM, Meilof JF, Somanje-Bolweg RRJ, et al.

    Case reports in neurology 2017; (9(1)):12-16 doi:10.1159/000455942.

    PMID: 28413400
  10. 10

    New therapies for neuromyelitis optica spectrum disorder.

    Levy M, Fujihara K, Palace J

    The Lancet. Neurology 2021; (20(1)):60-67 doi:10.1016/S1474-4422(20)30392-6.

    PMID: 33186537

This page explains NMOSD symptoms and attack recognition for educational purposes only. Always seek immediate emergency medical care if you suspect a new NMOSD attack.

Get notified when new evidence is published on Neuromyelitis optica spectrum disorder.

We monitor PubMed for new peer-reviewed studies on this topic and email a short summary when something meaningful changes.